FIELD: pharmacology.
SUBSTANCE: invention is a topical formulation for subcutaneous fat reduction, containing latanoprost, isopropyl myristate and petrolatum, wherein the concentration of isopropyl myristate is 1 to 20% w/w. The invention provides a more efficient delivery of latanoprost, has better spreadability, is easier to mix and disperse from the container as compared to the formulation based solely on petroleum jelly.
EFFECT: composition is well tolerated without causing skin or eye irritation, and is physically and chemically stable.
18 cl, 1 dwg, 5 tbl, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BIVALENT BROMODOMAIN INHIBITORS AND ROUTES OF USE THEREOF | 2016 |
|
RU2742035C2 |
| LITHIUM BENZOATE CO-CRYSTALS AND THEIR APPLICATIONS | 2017 |
|
RU2765625C2 |
| SODIUM BENZOATE COCRYSTALS AND THEIR USE | 2017 |
|
RU2771810C2 |
| NEUROACTIVE COMPOUNDS AND THEIR APPLICATION METHODS | 2015 |
|
RU2764702C2 |
| CYANOTHIENOTRIAZOLODIAZEPINES AND METHODS FOR THEIR USE | 2016 |
|
RU2750164C2 |
| METHODS OF SCREENING TO IDENTIFY THERAPEUTIC CANDIDATES FOR THE TREATMENT OF INTRAOCULAR DISEASES OR DISORDERS | 2019 |
|
RU2795857C2 |
| INSECTICIDE ANTHRANYLAMIDES | 2001 |
|
RU2278852C2 |
| DIHYDROPTERIDINONE DERIVATIVES AND USES THEREOF | 2015 |
|
RU2673944C2 |
| SELECTIVE ESTROGEN RECEPTOR INHIBITORS AND USE THEREOF | 2017 |
|
RU2734501C2 |
| NEUROACTIVE STEROIDS, COMPOSITIONS AND THEIR USE | 2012 |
|
RU2808165C2 |
